EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Artemisiae Iwayomogii Herba Protects Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity in Models of Parkinson’s Disease

Hanbyeol Lee, In Gyoung Ju, Jin Hee Kim, Yujin Choi iD, Seungmin Lee iD, Hi-Joon Park, Myung Sook Oh iD

Nutrients · 14.05.2025 · 17 (10) · 1672

DOI: 10.3390/nu17101672 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 14.05.2025. Verfasst von Hanbyeol Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Artemisia, Neuroprotective Agents, Plant Extracts. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Technology R&D Project through the Korea Health Industry Development Institute, Ministry of Health and Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Parkinson’s disease (PD) is a common neurodegenerative disease characterized by motor symptoms caused by the loss of dopaminergic neurons. While the pathophysiology of PD is still not fully understood, it is recognized that oxidative stress plays a major role in its progression. Previous studies have shown that the aerial parts of Artemisia iwayomogi Kitamura (AIK) possess medicinal properties, including antioxidant activity. This study aimed to investigate whether AIK can alleviate neuronal loss and motor symptoms in a PD model and to explore its therapeutic mechanisms.

Methods

For the in vitro study, PC12 cells were treated with AIK and 1-methyl-4-phenylpyridinium (MPP+). For the in vivo study, C57BL/6J mice were orally administered AIK for 12 days; they received intraperitoneal injections of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) for 5 consecutive days, starting on the 8th day of AIK administration.

Results

AIK treatment to PC12 cells in the presence of MPP+ enhanced the phosphorylation of the protein kinase B/glycogen synthase kinase-3β signaling pathway, which is a crucial regulator of nuclear factor erythroid 2-related factor 2 (Nrf2) translocation. Additionally, AIK treatment increased cell survival and induced an antioxidant response involving heme oxygenase-1, via increasing the level of Nrf2 in the nucleus. In an MPTP-induced mouse model of PD, AIK administration activated Nrf2 in dopaminergic neurons and prevented the loss of dopaminergic neurons in the brain, which in turn alleviated motor dysfunction.

Conclusions

Collectively, these findings suggest that AIK is a potential botanical candidate for PD treatment by protecting dopaminergic neurons through antioxidant activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dopaminergic NeuronsArtemisiaNeuroprotective AgentsPlant ExtractsParkinson DiseaseMPTP PoisoningAnimalsPC12 CellsRatsMice, Inbred C57BL1-Methyl-4-phenylpyridiniumMiceMaleDisease Models, AnimalNF-E2-Related Factor 21-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAntioxidantsOxidative Stress

Stichwörter der Autor:innen

Artemisia iwayomogiParkinson’s diseaseheme oxygenase-1nuclear factor erythroid 2-related factor 2

Substanzen

Neuroprotective Agents1-Methyl-4-phenylpyridiniumPlant ExtractsNF-E2-Related Factor 21-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAntioxidants

Autor:innen und Institutionen

  • Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Oriental Pharmaceutical Science and Kyung Hee East-West Pharmaceutical Research Institute, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Acupuncture and Meridian Science Research Center (AMSRC), Kyung Hee University, Seoul 02447, Republic of Korea.

ORCID-Profile: Yujin Choi, Seungmin Lee, Myung Sook Oh

Förderung

  • National Research Foundation of Korea
  • Korea Health Technology R&D Project through the Korea Health Industry Development Institute
  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Lee, H., Ju, I. G., Kim, J. H., Choi, Y., Lee, S., Park, H. J., & Oh, M. S. (2025). Artemisiae Iwayomogii Herba Protects Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity in Models of Parkinson’s Disease. Nutrients, 17(10), 1672. https://doi.org/10.3390/nu17101672

Vancouver

Lee H, Ju IG, Kim JH, Choi Y, Lee S, Park HJ, et al. Artemisiae Iwayomogii Herba Protects Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity in Models of Parkinson’s Disease. Nutrients. 2025;17(10):1672. doi:10.3390/nu17101672

BibTeX
@article{Lee2025,
  author = {Lee, Hanbyeol and Ju, In Gyoung and Kim, Jin Hee and Choi, Yujin and Lee, Seungmin and Park, Hi-Joon and Oh, Myung Sook},
  title = {Artemisiae Iwayomogii Herba Protects Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity in Models of Parkinson’s Disease},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1672},
  doi = {10.3390/nu17101672}
}
Kostenlos starten →